Article Details

CD19+22 CAR-T by Hebei Senlang Biotechnology for B-Cell Acute Lymphocytic Leukemia ...

Retrieved on: 2024-01-04 20:22:14

Tags for this article:

Click the tags to see associated articles and topics

CD19+22 CAR-T by Hebei Senlang Biotechnology for B-Cell Acute Lymphocytic Leukemia .... View article details on hiswai:

Excerpt

Hebei Senlang Biotechnology is a pharamaceutial and healthcare company which is involved in using bio technology for treatment of immune cells. The ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo